Catalyst Wire Dossier Catalyst Wire Dossier

Synthetic human secretin-enhanced MRCP

secretin · Repligen Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Synthetic human secretin-enhanced MRCP, covering 2009-12-03 to 2009-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas [Phase 3]

See pricing